NEW YORK (GenomeWeb News) – Gentronix today said that it has received a French research tax credit approval for the years 2012-2014.

The credit allows eligible research-intensive French companies who are subject to corporate tax in France the ability to claim tax relief on costs generated in R&D requirements that are outsourced to Gentronix. The firm is based in Manchester, UK, and provides genotoxicity screening products and services.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.